sglt2 inhibitors vs glp 1 agonists glp-1 View of Diabetes medications with cardiovascular protection after HARMONY Outcomes Frontiers | Effects of SGLT2

A Comprehensive Research Overview of GLP-1 Explore the science behind Tirzepatide peptide, a dual GLP-1/GIP receptor agonist studied for its role in glucose regulation, insulin sensitivity, and appetite modulation

However, not all patients with B12 deficiency develop anaemia

IV therapy might not be suitable for everyone

Why do syringe units change with syringe size

YM905, a novel M3 antagonist, inhibits Ca2+ signaling and c-fos gene expression mediated via muscarinic receptors in human T cells

Key developments include long-acting GH therapies such as somapacitan and lonapegsomatropin gaining FDA approvals for improved compliance in GH deficiency, shifting from daily injections to weekly administration